You are here

Our science / Clinical Trials / Find a Trial / NCT00798889

Rollover Protocol for Prior SU011248 Protocols

Back to Search Print Save as PDF Bookmark Trial

NCT00798889

Last updated on February 17, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Birmingham, Alabama, 35233-2115 United States
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Solid Tumors
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Prior SU011248 Protocol.

- Eligible to continue SU011248 treatment.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Uncontrolled CNS metastasis.

- Unfit to receive SU011248.

NCT00798889
Pfizer
Completed
Rollover Protocol for Prior SU011248 Protocols

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Advanced Cancer, Advanced Solid Tumors
Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors
NCT00729833
All Genders
18+
Years
Multiple Sites
Advanced Malignant Solid Tumors
Study of PKI-179 Administered Orally to Subjects With Solid Tumors
NCT00997360
All Genders
Advanced Solid Tumors
An Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800)
NCT02997176
All Genders
18+
Years
Multiple Sites
Advanced Solid Tumors
A Study of Talazoparib in Patients With Advanced Solid Tumors
NCT03070548
All Genders
18+
Years
Budapest,

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now